12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers
Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 228.5% to $7.26 during Tuesday's regular session. The company's market cap stands at $95.8 million.
Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings
Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
Pasithea Therapeutics Corp.
EXCLUSIVE: Pasithea Therapeutics’ Wholly Owned Subsidiary Pasithea Clinics To Launch In-Home Intravenous Ketamine Therapy In New York City, Los Angeles, San Diego, And San Francisco To Expand Its International Footprint
Miami Beach, FL / November 17, 2021 -- Pasithea Therapeutics Corp. (Nasdaq:
KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused
on the research and discovery of new and
64 Biggest Movers From Yesterday
Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
30 Stocks Moving in Thursday’s Pre-Market Session
Gainers
InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.